Terms: = Head and neck cancer AND HOXD13, SPD, 3239, P35453, HOX4I
44 results:
1. The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study.
Kurosaki T; Chamoto K; Suzuki S; Kanemura H; Mitani S; Tanaka K; Kawakami H; Kishimoto Y; Haku Y; Ito K; Sato T; Suminaka C; Yamaki M; Chiba Y; Yaguchi T; Omori K; Kobayashi T; Nakagawa K; Honjo T; Hayashi H
Front Immunol; 2023; 14():1325462. PubMed ID: 38149256
[TBL] [Abstract] [Full Text] [Related]
2. Spermidine Suppresses Oral Carcinogenesis through Autophagy Induction, DNA Damage Repair, and Oxidative Stress Reduction.
Coeli-Lacchini FB; da Silva G; Belentani M; Alves JSF; Ushida TR; Lunardelli GT; Garcia CB; Silva TA; Lopes NP; Leopoldino AM
Am J Pathol; 2023 Dec; 193(12):2172-2181. PubMed ID: 37741450
[TBL] [Abstract] [Full Text] [Related]
3. A near-infrared fluorescence-enhancing plasmonic biosensing microarray identifies soluble PD-L1 and ICAM-1 as predictive checkpoint biomarkers for cancer immunotherapy.
Lin Z; Liu M; Xing W; Wang F; Zhang H; Wei X; Schmitthenner H; Xie X; Xia X; Yang J
Biosens Bioelectron; 2023 Nov; 240():115633. PubMed ID: 37683502
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes of Short-Term Surgical Trips in Otolaryngology-head and neck Surgery: A Scoping Review.
Wiedermann J; Douse DM; Green KJ; Pang JC; Blount Q; Yu K; Shrime M
Laryngoscope; 2024 Jan; 134(1):32-39. PubMed ID: 37249184
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic and predictive role of soluble programmed death ligand-1 in head and neck cancer.
Molga-Magusiak M; Rzepakowska A; Żurek M; Kotuła I; Demkow U; Niemczyk K
Braz J Otorhinolaryngol; 2023; 89(3):417-424. PubMed ID: 36868994
[TBL] [Abstract] [Full Text] [Related]
6. Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Shiraishi T; Toyozumi T; Sakata H; Murakami K; Kano M; Matsumoto Y; Yokoyama M; Okada K; Kamata T; Ryuzaki T; Kinoshita K; Hirasawa S; Matsubara H
Oncology; 2022; 100(1):39-47. PubMed ID: 34991094
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Effects of Microwave Ablation in the Treatment of Low-Risk Papillary Thyroid Microcarcinomas and Related Histopathological Changes.
Lu C; Li X; Chu X; Li R; Li J; Wang J; Wang Y; Xu Y; Chen G; Xu S; Liu C
Front Endocrinol (Lausanne); 2021; 12():751213. PubMed ID: 34603216
[TBL] [Abstract] [Full Text] [Related]
8. Variation in Diagnosis, Treatment, and Outcome of Esophageal cancer in a Regionalized Care System in Ontario, Canada.
Habbous S; Yermakhanova O; Forster K; Holloway CMB; Darling G
JAMA Netw Open; 2021 Sep; 4(9):e2126090. PubMed ID: 34546371
[TBL] [Abstract] [Full Text] [Related]
9. The clinical implication of soluble PD-L1 (spd-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte.
Han B; Dong L; Zhou J; Yang Y; Guo J; Xuan Q; Gao K; Xu Z; Lei W; Wang J; Zhang Q
Cancer Immunol Immunother; 2021 Oct; 70(10):2893-2909. PubMed ID: 33688997
[TBL] [Abstract] [Full Text] [Related]
10. HGF-Induced PD-L1 Expression in head and neck cancer: Preclinical and Clinical Findings.
Boschert V; Teusch J; Aljasem A; Schmucker P; Klenk N; Straub A; Bittrich M; Seher A; Linz C; Müller-Richter UDA; Hartmann S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233528
[TBL] [Abstract] [Full Text] [Related]
11. PD-L1, PDK-1 and p-Akt are correlated in patients with papillary thyroid carcinoma.
Wang H; Zhang Z; Yan Z; Ma S
Adv Clin Exp Med; 2020 Jul; 29(7):785-792. PubMed ID: 32750756
[TBL] [Abstract] [Full Text] [Related]
12. Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively.
Corsini EM; Wang Q; Tran HT; Mitchell KG; Antonoff MB; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Swisher SG; Vaporciyan AA; Walsh GL; Reuben A; Vasquez ME; Bernatchez C; Wang J; Cascone T; Zhang J; Heymach JV; Gibbons DL; Haymaker CL; Sepesi B
Lung Cancer; 2020 Aug; 146():303-309. PubMed ID: 32619781
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma.
Singh L; Singh MK; Rizvi MA; Pushker N; Bakhshi S; Sen S; Kashyap S
Br J Ophthalmol; 2021 Jan; 105(1):48-56. PubMed ID: 32277010
[TBL] [Abstract] [Full Text] [Related]
14. Plasma levels of soluble programmed death ligand 1 (spd-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary study.
Yang J; Hu M; Bai X; Ding X; Xie L; Ma J; Fan B; Yu J
Medicine (Baltimore); 2019 Sep; 98(39):e17231. PubMed ID: 31574833
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy.
Ruan Y; Hu W; Li W; Lu H; Gu H; Zhang Y; Zhu C; Chen Q
Biomed Res Int; 2019; 2019():3939720. PubMed ID: 31192256
[TBL] [Abstract] [Full Text] [Related]
16. Clinical significance of soluble forms of immune checkpoint molecules in advanced esophageal cancer.
Yoshida J; Ishikawa T; Doi T; Ota T; Yasuda T; Okayama T; Sakamoto N; Inoue K; Dohi O; Yoshida N; Kamada K; Uchiyama K; Takagi T; Konishi H; Naito Y; Itoh Y
Med Oncol; 2019 May; 36(7):60. PubMed ID: 31134385
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Significance of PD-L1
Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
[TBL] [Abstract] [Full Text] [Related]
18. Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate.
Sun CY; Walker CM; Michel KA; Venkatesan AM; Lai SY; Bankson JA
Magn Reson Med; 2018 Jun; 79(6):3239-3248. PubMed ID: 29090487
[TBL] [Abstract] [Full Text] [Related]
19. HOXB9 Expression Correlates with Histological Grade and Prognosis in LSCC.
Sun C; Han C; Wang P; Jin Y; Sun Y; Qu L
Biomed Res Int; 2017; 2017():3680305. PubMed ID: 28808656
[TBL] [Abstract] [Full Text] [Related]
20. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
[TBL] [Abstract] [Full Text] [Related]
[Next]
